Heart Test Laboratories Past Earnings Performance
Past criteria checks 0/6
Heart Test Laboratories's earnings have been declining at an average annual rate of -19.5%, while the Medical Equipment industry saw earnings growing at 11.1% annually. Revenues have been declining at an average rate of 49.8% per year.
Key information
-19.5%
Earnings growth rate
16.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -49.8% |
| Return on equity | -74.0% |
| Net Margin | -34,362.4% |
| Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Heart Test Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 0 | -6 | 4 | 2 |
| 31 Oct 23 | 0 | -6 | 3 | 3 |
| 31 Jul 23 | 0 | -6 | 3 | 3 |
| 30 Apr 23 | 0 | -6 | 4 | 2 |
| 31 Jan 23 | 0 | -7 | 3 | 3 |
| 31 Oct 22 | 0 | -7 | 3 | 3 |
| 31 Jul 22 | 0 | -6 | 2 | 3 |
| 30 Apr 22 | 0 | -5 | 2 | 3 |
| 31 Jan 22 | 0 | -4 | 1 | 2 |
| 30 Apr 21 | 0 | -2 | 1 | 2 |
| 30 Apr 20 | 0 | -4 | 2 | 2 |
Quality Earnings: HSCS is currently unprofitable.
Growing Profit Margin: HSCS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HSCS is unprofitable, and losses have increased over the past 5 years at a rate of 19.5% per year.
Accelerating Growth: Unable to compare HSCS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HSCS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).
Return on Equity
High ROE: HSCS has a negative Return on Equity (-74.03%), as it is currently unprofitable.